RecruitingNot ApplicableNCT06556407

Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis

Effect of Renal Denervation on Blood Pressure in Patients With Treatment Resistant Hypertension, End-stage Chronic Kidney Disease and Hemodialysis


Sponsor

University of Erlangen-Nürnberg Medical School

Enrollment

12 participants

Start Date

Mar 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The RDN-HD Study is a prospective, single-center feasibility study. All patients included will undergo endovascular ultrasound-based RDN (no sham group, no blinding). The purpose of the RDN-HD Study is to demonstrate that ultrasound-based RDN is safe in patients with TRH and ESRD hemodialysis and reduces 24-h ambulatory BP.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a procedure called renal denervation — where nerve signals to the kidneys are interrupted using a thin tube (catheter) — can help lower blood pressure in patients whose high blood pressure is extremely hard to control, even while on dialysis for kidney failure. **You may be eligible if...** - You are 18 or older with end-stage kidney disease on regular dialysis - You have uncontrolled high blood pressure despite taking at least 3 different blood pressure medications - Your dialysis routine has been stable for at least 3 months **You may NOT be eligible if...** - You have had a prior renal denervation procedure - You have had a heart attack, stroke, or unstable chest pain in the past 3 months - You have significant narrowing or structural problems in your kidney arteries - You have only one functioning kidney or a transplanted kidney - You have high blood pressure caused by a hormonal condition other than sleep apnea Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICErenal denervation

ultrasound based renal denervation


Locations(1)

Friedrich Alexander University Erlangen Nuremberg, Department of Nephrology and Hypertension

Erlangen, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06556407


Related Trials